More
    Guided Solutions - Connecting Talent With Innovation/div>

    Signum Surgical’s BioHealx technology obtains FDA clearance

    Signum Surgical has secured De Novo clearance from the US Food and Drug Administration (FDA) for its BioHealx technology for anal fistula treatment. BioHealx is...

    FDA brings Paradromics BCI into advisory program

    Brain-computer interface (BCI) developer Paradromics announced today that the FDA accepted it into its Total Product Life Cycle Advisory Program (TAP). TAP provides early...

    FDA issues 510(k) approval for Epica’s See Factor CT3 system

    Epica International has announced an updated 510(k) clearance from the US Food and Drug Administration (FDA) for its See Factor CT3 System. This clearance signifies...

    FDA clears IceCure Medical’s next-gen single-probe cryoablation system

    IceCure Medical announced the FDA granted clearance for its next-generation single-probe cryoablation system. The XSense cryoablation system with CryoProbes received clearance for all indications...

    CeQur wins FDA nod for mealtime insulin delivery device

    CeQur announced recently that the FDA granted 510(k) clearance for its Simplicity system for an extended wear duration. Clearance extends the wear time for...

    FDA expands Fractyl endoscopy trial to include untreated diabetes patients

    The US FDA has given the green light for metabolic therapeutics company, Fractyl Health, to expand the  REVITALIZE-1 clinical study for  its endoscopic device...

    FDA approves Endotronix Cordella PA sensor system for heart failure treatment

    Endotronix today announced it received FDA premarket approval for its Cordella PA Sensor System. The Naperville, Illinois=based company designed the Cordella Pulmonary Artery (PA)...

    Nexalin wins US patent for Alzheimer’s deep-brain stimulation device

    Nexalin Technology has secured a US patent for its non-invasive, frequency-based, deep-brain stimulation device aimed at treating Alzheimer’s and dementia. The US Patent and Trademark...

    Elixir Medical wins FDA breakthrough nod for sirolimus-eluting bioadaptor system

    Elixir Medical received FDA breakthrough device designation for its DynamX bioadaptive implant. The breakthrough nod covers the improvement of coronary luminal diameter, restoration of...

    Latest articles